相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanistic insights into the effect of phosphorylation on Ras conformational dynamics and its interactions with cell signaling proteins
Yuanhao Wang et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Therapeutic targeting of RAS: New hope for drugging the undruggable
Imran Khan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors
Brian A. Lanman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Targeting NRAS-Mutant Cancers with the Selective STK19 Kinase Inhibitor Chelidonine
Ling Qian et al.
CLINICAL CANCER RESEARCH (2020)
Combining Allosteric and Orthosteric Drugs to Overcome Drug Resistance
Duan Ni et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Evidence That STK19 Is Not an NRAS-dependent Melanoma Driver
Marta Rodriguez-Martinez et al.
CELL (2020)
A Reply to Evidence that STK19 Is Not an NRAS-Dependent Melanoma Driver''
Chengqian Yin et al.
CELL (2020)
RAS-targeted therapies: is the undruggable drugged?
Amanda R. Moore et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
GSK3 Inhibits Macropinocytosis and Lysosomal Activity through the Wnt Destruction Complex Machinery
Lauren Albrecht et al.
CELL REPORTS (2020)
A conserved, N-terminal tyrosine signal directs Ras for inhibition by Rabex-5
Chalita Washington et al.
PLOS GENETICS (2020)
Direct inhibition of RAS: Quest for the Holy Grail?
Russell Spencer-Smith et al.
SEMINARS IN CANCER BIOLOGY (2019)
Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis
Chengqian Yin et al.
CELL (2019)
Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
Shaoyong Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Targeting the untargetable KRAS in cancer therapy
Pingyu Liu et al.
ACTA PHARMACEUTICA SINICA B (2019)
AlloDriver: a method for the identification and analysis of cancer driver targets
Kun Song et al.
NUCLEIC ACIDS RESEARCH (2019)
Drugging K-RasG12C through covalent inhibitors: Mission possible?
Duan Ni et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Deactivation Pathway of Ras GTPase Underlies Conformational Substates as Targets for Drug Design
Shaoyong Lu et al.
ACS CATALYSIS (2019)
Conformational and Dynamical Effects of Tyr32 Phosphorylation in K-Ras: Molecular Dynamics Simulation and Markov State Models Analysis
Mohammed Khaled et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2019)
Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D
Christian W. Johnson et al.
CELL REPORTS (2019)
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Jude Canon et al.
NATURE (2019)
Cracking KRAS
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2019)
AlloMAPS: allosteric mutation analysis and polymorphism of signaling database
Zhen Wah Tan et al.
NUCLEIC ACIDS RESEARCH (2019)
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation
Yoshihito Kano et al.
NATURE COMMUNICATIONS (2019)
Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms
Shaoyong Lu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
The K-Ras, N-Ras, and H-Ras Isoforms: Unique Conformational Preferences and Implications for Targeting Oncogenic Mutants
Jillian A. Parker et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
Nithya Krishnamurthy et al.
CANCER TREATMENT REVIEWS (2018)
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
Matthew R. Janes et al.
CELL (2018)
Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy
Federico Rossari et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
Dietrich A. Ruess et al.
NATURE MEDICINE (2018)
CavityPlus: a web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction
Youjun Xu et al.
NUCLEIC ACIDS RESEARCH (2018)
AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses
Min Huang et al.
NUCLEIC ACIDS RESEARCH (2018)
Raf-1 Cysteine-Rich Domain Increases the Affinity of K-Ras/Raf at the Membrane, Promoting MAPK Signaling
Shuai Li et al.
STRUCTURE (2018)
Phosphorylation promotes binding affinity of Rap-Raf complex by allosteric modulation of switch loop dynamics
T. Devanand et al.
SCIENTIFIC REPORTS (2018)
Therapeutic strategies to target RAS-mutant cancers
Meagan B. Ryan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Improved Method for the Identification and Validation of Allosteric Sites
Kun Song et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1
Andrew A. Wylie et al.
NATURE (2017)
RAS Proteins and Their Regulators in Human Disease
Dhirendra K. Simanshu et al.
CELL (2017)
Phosphorylation Weakens but Does Not Inhibit Membrane Binding and Clustering of K-Ras4B
Si-Yu Zhang et al.
ACS CHEMICAL BIOLOGY (2017)
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Roel Nusse et al.
CELL (2017)
Multivalent Small-Molecule Pan-RAS Inhibitors
Matthew E. Welsch et al.
CELL (2017)
Proteome-Scale Investigation of Protein Allosteric Regulation Perturbed by Somatic Mutations in 7,000 Cancer Genomes
Qiancheng Shen et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
The RAS-Effector Interaction as a Drug Target
Adam B. Keeton et al.
CANCER RESEARCH (2017)
Latest Advances Towards Ras Inhibition: A Medicinal Chemistry Perspective
Brice Sautier et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Ras Conformational Ensembles, Allostery, and Signaling
Shaoyong Lu et al.
CHEMICAL REVIEWS (2016)
Emerging Computational Methods for the Rational Discovery of Allosteric Drugs
Jeffrey R. Wagner et al.
CHEMICAL REVIEWS (2016)
Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view
Shaoyong Lu et al.
CHEMICAL SOCIETY REVIEWS (2016)
Drug developers refocus efforts on RAS
Cormac Sheridan
NATURE BIOTECHNOLOGY (2016)
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
Ximena Bonilla et al.
NATURE GENETICS (2016)
RAS mimetic revealed
Alexandra Flemming
NATURE REVIEWS DRUG DISCOVERY (2016)
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design
Jonathan M. L. Ostrem et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Multiomic Analysis of the UV-Induced DNA Damage Response
Stefan Boeing et al.
CELL REPORTS (2016)
Structure-Based Statistical Mechanical Model Accounts for the Causality and Energetics of Allosteric Communication
Enrico Guarnera et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Direct Modulation of Small GTPase Activity and Function
Philipp M. Cromm et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Post-transcriptional Wnt Signaling Governs Epididymal Sperm Maturation
Stefan Koch et al.
CELL (2015)
Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding
Pamela Y. Ting et al.
FASEB JOURNAL (2015)
Mechanisms of Membrane Binding of Small GTPase K-Ras4B Farnesylated Hypervariable Region
Hyunbum Jang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Functions of Shp2 in cancer
Jie Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2015)
Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
Severa Bunda et al.
NATURE COMMUNICATIONS (2015)
Targeting RAS-mutant Cancers: Is ERK the Key?
Meagan B. Ryan et al.
TRENDS IN CANCER (2015)
Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth
Carles Barcelo et al.
CANCER RESEARCH (2014)
Recent computational advances in the identification of allosteric sites in proteins
Shaoyong Lu et al.
DRUG DISCOVERY TODAY (2014)
The impact of TP53 and RAS mutations on cerebellar glioblastomas
Vedrana P. Milinkovic et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)
Mitotic Wnt Signaling Promotes Protein Stabilization and Regulates Cell Size
Sergio P. Acebron et al.
MOLECULAR CELL (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation
Severa Bunda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Structural Basis of ATP as an Allosteric Modulator
Shaoyong Lu et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Allostery in Disease and in Drug Discovery
Ruth Nussinov et al.
CELL (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
Phosphorylated K-Ras limits cell survival by blocking Bcl-xL sensitization of inositol trisphosphate receptors
Pamela J. Sung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
p120RasGAP-Mediated Activation of c-Src Is Critical for Oncogenic Ras to Induce Tumor Invasion
Po-Chao Chan et al.
CANCER RESEARCH (2012)
A Comprehensive Survey of Ras Mutations in Cancer
Ian A. Prior et al.
CANCER RESEARCH (2012)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Protein kinase C, an elusive therapeutic target?
Daria Mochly-Rosen et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
Till Maurer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ras Stabilization Through Aberrant Activation of Wnt/β-Catenin Signaling Promotes Intestinal Tumorigenesis
Woo-Jeong Jeong et al.
SCIENCE SIGNALING (2012)
Targeting Src family kinases in anti-cancer therapies: turning promise into triumph
Siyuan Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Analysis of Binding Site Hot Spots on the Surface of Ras GTPase
Greg Buhrman et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Oncogenic Ras/Src cooperativity in pancreatic neoplasia
D. J. Shields et al.
ONCOGENE (2011)
Rabex-5 Ubiquitin Ligase Activity Restricts Ras Signaling to Establish Pathway Homeostasis in Drosophila
Hua Yan et al.
CURRENT BIOLOGY (2010)
Feedback Regulation of Ras Signaling by Rabex-5-Mediated Ubiquitination
Lizhong Xu et al.
CURRENT BIOLOGY (2010)
Ras oncogenes: split personalities
Antoine E. Karnoub et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis
TG Bivona et al.
MOLECULAR CELL (2006)
分享论文
